These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 35598140)
1. COVID-19 and Mucormycosis in India a Study on Implicated Risk Factors. Deepak P; Rao MR; Mandadi K J Assoc Physicians India; 2022 May; 70(5):11-12. PubMed ID: 35598140 [No Abstract] [Full Text] [Related]
2. The emergence of post-COVID-19 mucormycosis in India: Can we prevent it? Gupta A; Sharma A; Chakrabarti A Indian J Ophthalmol; 2021 Jul; 69(7):1645-1647. PubMed ID: 34146000 [No Abstract] [Full Text] [Related]
5. Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave? Raut A; Huy NT Lancet Respir Med; 2021 Aug; 9(8):e77. PubMed ID: 34090607 [No Abstract] [Full Text] [Related]
8. Mucormycosis: An unanticipated progeny of COVID-19. Shrestha GS; Bhandari S; Lamsal R; Gurung U JNMA J Nepal Med Assoc; 2021 Sep; 59(241):965-967. PubMed ID: 35199723 [TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of COVID-19-associated mucormycosis (CAM) in India: probing the triggering factors. Arakeri G; Patil S; Rao Us V; Amaral Mendes R; Oeppen RS; Brennan PA Br J Oral Maxillofac Surg; 2022 May; 60(4):e533-e534. PubMed ID: 35351328 [No Abstract] [Full Text] [Related]
10. Five probable factors responsible for the COVID-associated mucormycosis outbreak in India. Ravindra K; Ahlawat A Int J Infect Dis; 2021 Nov; 112():278-280. PubMed ID: 34592439 [TBL] [Abstract][Full Text] [Related]
11. Mucormycosis Epidemic and Stroke in India During the COVID-19 Pandemic. Padma Srivastava MV; Vishnu VY; Pandit AK Stroke; 2021 Oct; 52(10):e622-e623. PubMed ID: 34525840 [No Abstract] [Full Text] [Related]
12. COVID-19 associated mucormycosis (CAM) in India: a formidable challenge. Rao VUS; Arakeri G; Madikeri G; Shah A; Oeppen RS; Brennan PA Br J Oral Maxillofac Surg; 2021 Nov; 59(9):1095-1098. PubMed ID: 34507870 [TBL] [Abstract][Full Text] [Related]
13. COVID-19 and mucormycosis syndemic: double health threat to a collapsing healthcare system in India. Rocha ICN; Hasan MM; Goyal S; Patel T; Jain S; Ghosh A; CedeƱo TDD Trop Med Int Health; 2021 Sep; 26(9):1016-1018. PubMed ID: 34117677 [TBL] [Abstract][Full Text] [Related]
14. [COVID-19 associated mucormycosis. A case in Argentina]. Aparicio M; Tuculet B; Rivolier MG; Forte A; Vila A Medicina (B Aires); 2022; 82(2):304-307. PubMed ID: 35417397 [TBL] [Abstract][Full Text] [Related]
15. The "Black Fungus" in India: The Emerging Syndemic of COVID-19-Associated Mucormycosis. Gandra S; Ram S; Levitz SM Ann Intern Med; 2021 Sep; 174(9):1301-1302. PubMed ID: 34097436 [TBL] [Abstract][Full Text] [Related]
16. An Epidemic of Mucormycosis Coinciding With the COVID-19 Pandemic in India. MohanaSundaram A; Thukani Sathanantham S; Kulkarni A; Kulkarni S; Chinchole V; Patil B; Velayutham R Asia Pac J Public Health; 2022 Mar; 34(2-3):304-305. PubMed ID: 34779277 [No Abstract] [Full Text] [Related]
17. Implications of the second wave of COVID-19 in India. Asrani P; Eapen MS; Hassan MI; Sohal SS Lancet Respir Med; 2021 Sep; 9(9):e93-e94. PubMed ID: 34216547 [No Abstract] [Full Text] [Related]
18. Mucormycosis in COVID-19 patients. Sundaram N; Bhende T; Yashwant R; Jadhav S; Jain A Indian J Ophthalmol; 2021 Dec; 69(12):3728-3733. PubMed ID: 34827032 [TBL] [Abstract][Full Text] [Related]
19. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India. Singh AK; Singh R; Joshi SR; Misra A Diabetes Metab Syndr; 2021; 15(4):102146. PubMed ID: 34192610 [TBL] [Abstract][Full Text] [Related]